0001104659-20-079120.txt : 20200630
0001104659-20-079120.hdr.sgml : 20200630
20200630173553
ACCESSION NUMBER: 0001104659-20-079120
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200626
FILED AS OF DATE: 20200630
DATE AS OF CHANGE: 20200630
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Simons Emmanuel
CENTRAL INDEX KEY: 0001815162
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39343
FILM NUMBER: 201003256
MAIL ADDRESS:
STREET 1: C/O AKOUOS, INC.
STREET 2: 645 SUMMER STREET SUITE 200
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akouos, Inc.
CENTRAL INDEX KEY: 0001722271
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 645 SUMMER STREET, SUITE 200
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 857-245-5715
MAIL ADDRESS:
STREET 1: 645 SUMMER STREET, SUITE 200
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
a4.xml
4
X0306
4
2020-06-26
0
0001722271
Akouos, Inc.
AKUS
0001815162
Simons Emmanuel
C/O AKOUOS, INC.
645 SUMMER STREET SUITE 200
BOSTON
MA
02210
1
1
1
0
President and CEO
Common Stock
2020-06-26
4
C
0
35312
A
35312
D
Series Seed-1 Preferred Stock
2020-06-30
4
C
0
35312
0.00
D
Common Stock
35312
0
D
Stock Option (right to buy)
17.00
2020-06-26
4
A
0
838066
0.00
A
2030-06-17
Common Stock
838066
838066
D
On June 30, 2020, the Series Seed-1 Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series Seed-1 Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
The option was granted on June 18, 2020, effective as of and contingent upon the commencement of trading of the Issuer's shares of common stock on the Nasdaq Global Select Market, which occurred on June 26, 2020. The shares underlying the option vest over four years in equal monthly installments from June 18, 2020 through June 18, 2024.
/s/ Karoline K. Shair, Attorney-in-Fact For Emmanuel Simons
2020-06-30